R, R., M, B., C, B., K, C., T, D., T, F., . . . SF, K. (2025). Clinical utility and cost-effectiveness of BeginNGS newborn screening by genome sequencing and standard newborn screening for severe childhood genetic diseases: An adaptive, international and comparative clinical trial. BMJ open, 15(11), e098609. https://doi.org/10.1136/bmjopen-2024-098609
Chicago Style (17th ed.) CitationR, Reimers, et al. "Clinical Utility and Cost-effectiveness of BeginNGS Newborn Screening by Genome Sequencing and Standard Newborn Screening for Severe Childhood Genetic Diseases: An Adaptive, International and Comparative Clinical Trial." BMJ Open 15, no. 11 (2025): e098609. https://doi.org/10.1136/bmjopen-2024-098609.
MLA (9th ed.) CitationR, Reimers, et al. "Clinical Utility and Cost-effectiveness of BeginNGS Newborn Screening by Genome Sequencing and Standard Newborn Screening for Severe Childhood Genetic Diseases: An Adaptive, International and Comparative Clinical Trial." BMJ Open, vol. 15, no. 11, 2025, p. e098609, https://doi.org/10.1136/bmjopen-2024-098609.
